Cloudbyz

JULY 2, 2024

Understanding the exceptions in Informed consent is an essential aspect of ethical clinical research because it concerns full awareness of risks and benefits related to research, as well as procedures. This is particularly relevant for infectious diseases where rapid diagnosis and treatment are important in disease control before its spread.

In-Vitro 99

In-Vitro Trials Clinical Trials Clinical Trials 99

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 5, 2024

Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi has emphasised that the medical devices and in-vitro diagnostics (IVD) sold in the county should be tested for the standards prescribed by the Bureau of Indian Standards (BIS) for its quality and performance in the country.

In-Vitro 189

In-Vitro Drugs Clinical Trials Clinical Trials 189

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 22, 2024

All the medical devices including in-vitro diagnostic medical devices have come under the regulation […]

In-Vitro 188

In-Vitro Licensing Licensing Regulation 188

Pharma Mirror

MARCH 8, 2021

1] It became continually challenging in targeting KRAS transformation bearing tumors in view of the unclear construction of the protein, however by a wide margin but AMG 510, an effective inhibitor was brought into these clinical preliminaries. [2] 2] Presumably, fenbendazole multitherapy along with this little.

In-Vitro 246

In-Vitro Drugs Protein Research 246

Pharma Mirror

SEPTEMBER 2, 2021

In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19.

In-Vitro 245

In-Vitro RNA Clinical Trials Clinical Trials 245

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2023

The Drug Controller General of India (DCGI) has added in-vitro diagnostic (IVD) medical devices including those for diagnosis of Covid-19, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) extraction kits, among others into the Class C risk category under the Medical Devices Rules (MDR), 2017.

RNA 189

RNA DNA In-Vitro Drugs 189

Pharmaceutical Technology

SEPTEMBER 19, 2022

The combination therapy was also found to retain in vitro neutralisation of SARS-CoV-2 virus’ Omicron BA.5 The combination therapy was also found to retain in vitro neutralisation of SARS-CoV-2 virus’ Omicron BA.5 Additionally, in the trial, the antibody cocktail was found to be well-tolerated. 5 variant, the company noted.

In-Vitro 279

In-Vitro Antibody Vaccine Vaccination 279

Medical Xpress

MARCH 1, 2023

In the worst-case scenario, getting chemicals in your eyes can lead to blindness. Until now, the eye irritancy potential of chemical substances has had to be assessed using the Draize test on live rabbits—a standard implemented worldwide.

In-Vitro 96

In-Vitro 96

Bio Pharma Dive

FEBRUARY 28, 2024

The company is still attempting to “monetize” its most advanced drug, a treatment to aid pregnancy via in vitro fertilization.

In-Vitro 133

In-Vitro Drugs 133

BioSpace

JULY 19, 2021

Preclinical data for its drug candidate, LP-184, reportedly showed over 90 percent efficacy in shrinking pancreatic cancer tumors in mouse models in vitro, in-vivo, and ex-vivo.

In-Vivo 145

In-Vivo In-Vitro Drugs 145

Pharmaceutical Technology

MAY 4, 2023

The approval allows KALYDECO to be used in infants who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to the therapy, on the basis of clinical and/or in vitro assay results. This cohort showed a safety profile identical to that found in older children and adults.

In-Vitro 246

In-Vitro Genetic Disease Medicine Genetics 246

Pharmaceutical Technology

OCTOBER 5, 2022

Autologous CAR-T therapy does not easily lend itself to treating CLL, as it relies on extracting functional T-cells from the patient’s blood and genetically modifying them in vitro. Autologous CAR-T agents are now becoming the standard of care for patients in the third line and later settings, providing lucrative returns for these agents.

In-Vitro 279

In-Vitro In-Vivo Sales Clinical Trials 279

BioSpace

JANUARY 25, 2021

An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient.

In-Vitro 145

In-Vitro Scientist 145

Medical Xpress

MAY 16, 2023

That was the case when Thilini Gamage was to carry out one of the studies in her doctoral work with Professor Eirik Frengen at the Institute of Clinical Medicine, University of Oslo. They study gene variation and mutations that cause rare genetic diseases. A mutation is a permanent change in the genetic material.

In-Vitro 98

In-Vitro In-Vivo Genetic Disease Genetics 98

pharmaphorum

APRIL 9, 2024

Navigating the complex path towards commercialising In Vitro Diagnostics (IVDs) can be challenging. Learn more about the intricate process involved in bringing early diagnostic tools to market.

In-Vitro 116

In-Vitro Marketing 116

Pharmaceutical Technology

JANUARY 4, 2023

A synergistic activity was also observed between the anti-Gremlin1 antibody and enzalutamide against castration-resistant prostate cancer models derived from patients in vitro and in vivo. TST003 is a first-in-class Gremlin1 targeting humanised monoclonal antibody.

Antibody 242

Antibody In-Vivo In-Vitro Protein 242

BioPharma Reporter

JANUARY 28, 2021

In vitro studies found the Pfizer/BioNTech COVID-19 vaccine elicits antibodies against both the UK and South African virus strains.

In-Vitro 115

In-Vitro Vaccine Vaccination Antibody 115

Scienmag

OCTOBER 20, 2020

The cover for issue 31 of Oncotarget features Figure 4, ‘Concentration dose-response curves of sirolimus effect [55 nM-1 nM] on the number of cells per surviving colony in U2OS cell line after 2 weeks exposure,’ by Vasuri, et al. Credit: Correspondence to – Gianandrea Pasquinelli – gianandr.pasquinelli@unibo.it

In-Vitro 79

In-Vitro Medicine 79

World of DTC Marketing

JULY 12, 2021

And both companies have performed in vitro tests that demonstrate satisfactory vaccine efficacy against variants of concern. SUMMARY: Pfizer says it has data on waning immunity from their COVID vaccine. The FDA and CDC say “not so fast.” ” Booster shots could bring billions in revenue to Pfizer and Moderna.

Vaccine 292

Vaccine Vaccination In-Vitro Doctor 292

Pharmaceutical Technology

APRIL 14, 2023

All the new GD2 CAR designs developed through the partnership will be validated via in vitro screens and in vivo murine models. All the new GD2 CAR designs developed through the partnership will be validated via in vitro screens and in vivo murine models. Topic sponsors are not involved in the creation of editorial content.

In-Vivo 264

In-Vivo Gene Therapy In-Vitro Engineer 264

Medical Xpress

APRIL 11, 2023

In the process of organoid manufacturing, bioprinting technology can not only facilitate the creation and maintenance of complex biological 3D shapes and structures, but also allow for standardization and quality control during production.

In-Vitro 73

In-Vitro Manufacturing Production 73

Pharma Mirror

APRIL 21, 2024

In vitro transcribed (IVT) mRNA has been successfully The post General Design Methods for mRNA Drugs appeared first on Pharma Mirror Magazine. Scientists have been striving to optimize mRNA stability, immunogenicity, translation efficiency, and delivery systems to achieve efficient and safe mRNA delivery.

In-Vitro 130

In-Vitro Drugs Genetic Disease RNA 130

Pharmaceutical Technology

JULY 15, 2022

Despite entering its fourth decade of availability, in vitro fertilization (IVF), a medical technique used to facilitate the conception of a baby for those facing fertility problems, remains an elusive dream for many. Doing so will be vital in slowing the pace at which populations are ageing. Ageing populations increase the need to breed.

In-Vitro 264

In-Vitro Production Regulation Research 264

WCG Clinical

NOVEMBER 20, 2023

To view it please enter your password below: Password: The post A Review Of The Regulatory Landscape for In Vitro Gametogenesis appeared first on WCG. This content is password protected.

In-Vitro 40

In-Vitro 40

Pharma Mirror

AUGUST 30, 2022

The Test Bed utilizes Cytocentric principles, an innovative philosophy of putting the needs of the vulnerable cells front and center while growing and manipulating them in vitro. By eliminating the fluctuations and suboptimal transients caused by.

Medicine 130

Medicine In-Vitro Manufacturing Production 130

Medical Xpress

MAY 15, 2023

A new research paper, titled "In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers," was published on the cover of Aging

In-Vivo 98

In-Vivo In-Vitro Research 98

Scienmag

OCTOBER 24, 2021

Many diagnosed patients relapse, despite radical resection of the primary oral squamous cell carcinoma (OSCC) lesion. Therefore, understanding the local invasion mechanism is warranted in developing more effective therapeutic approaches, and identifying markers that predict poor prognosis. Credit: Niigata University Niigata, Japan – […].

In-Vitro 67

In-Vitro In-Vivo Development 67

Outsourcing Pharma

JANUARY 18, 2022

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.

In-Vitro 94

In-Vitro Research 94

Pharma Mirror

FEBRUARY 18, 2021

Maculus plans to raise USD3 million on a USD8 million valuation for a 12-18 month period, including initial in-vivo animal studies and completion of in-vitro / in-vivo drug elution studies. Maculus achieved the breakthrough using a patented novel tunable biodegradable proprietary product, MacuBloc. Capable of delivering any FDA approved.

Drug Delivery 130

Drug Delivery In-Vivo In-Vitro Drugs 130

XTalks

JANUARY 15, 2021

Ortho Clinical Diagnostics received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its VITROS SARS-CoV-2 antigen test for detection of active COVID-19 infection. The company says it can deliver five million tests a month and can increase to 15 million tests a month by February. active virus).

In-Vitro 105

In-Vitro Vaccine Vaccination Drugs 105

Medical Xpress

JANUARY 25, 2023

Research from Dr. Michael Golding's laboratory at Texas A&M University indicates that male alcohol use has a significant negative influence on in vitro fertilization (IVF) success rates, thus increasing patient financial burden and emotional stress.

In-Vitro 98

In-Vitro Research 98

BioPharma Reporter

JANUARY 25, 2021

An in vitro study shows Moderna's existing mRNA COVID-19 vaccine provides protection against strains that have emerged from South Africa and the UK. But it does suggest reduced protection against the South Africa strain, and so the company is also developing a new booster designed for maximum efficacy against this variant.

Vaccine 103

Vaccine Vaccination In-Vitro Development 103

Medical Xpress

JANUARY 23, 2023

The new approach worked more quickly than existing techniques to eliminate clots formed in an in vitro model of cerebral venous sinus thrombosis (CVST). Researchers have developed a new tool and technique that uses "vortex ultrasound"—a sort of ultrasonic tornado—to break down blood clots in the brain.

In-Vitro 98

In-Vitro Development Research Cardiology 98

Pharma Times

JANUARY 27, 2021

System will allow ‘in vitro diagnostics devices a faster and easier route to market’

In-Vitro 88

In-Vitro Marketing 88

Scienmag

JUNE 29, 2021

Oncotarget published “High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC” which reported that the aim of […].

In-Vivo 96

In-Vivo In-Vitro Protein Medicine 96

Pharmaceutical Technology

MAY 5, 2023

TFF Pharmaceuticals and NIEHS will investigate the TFF-HMW-HA formulations’ therapeutic efficacy and pharmacokinetics using in vitro and in vivo models of respiratory diseases.

Development 162

Development In-Vivo In-Vitro Engineer 162

Scienmag

FEBRUARY 11, 2022

To answer this question, a team from the University of Geneva (UNIGE), Switzerland, forced muscle cells to spontaneously reproduce simple shapes in vitro. By confining them on adhesion discs, the biochemists and physicists observed that the cells rapidly self-organise by aligning themselves in the same […].

In-Vitro 96

In-Vitro 96